TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -15.8% ·
share flow +2.3% ·
net new positions -18.8%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.73M | $5.62B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.40M | +2.5% | $235.47M | 1.7% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 6.28M | — | $230.91M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 5.83M | — | $214.53M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passive) | 5.83M | — | $214.53M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passive) | 5.83M | — | $214.53M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passive) | 5.83M | — | $214.53M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passive) | 5.83M | — | $214.53M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 2.50M | -7.2% | $92.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 2.16M | +50.6% | $79.41M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 1.50M | +40.4% | $55.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 1.50M | +40.4% | $55.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passive) | 1.42M | +0.3% | $52.41M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passive) | 1.42M | +0.3% | $52.41M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 775.69K | +6.0% | $28.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 775.69K | +6.0% | $28.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Baillie Gifford ✦ | 775.69K | +6.0% | $28.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Baillie Gifford ✦ | 775.69K | +6.0% | $28.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Millennium Management ✦ | 713.13K | +131.4% | $26.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 577.06K | -24.2% | $21.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 577.06K | -24.2% | $21.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 577.06K | -24.2% | $21.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 577.06K | -24.2% | $21.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 577.06K | -24.2% | $21.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 217.11K | — | $7.99M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 217.11K | — | $7.99M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 148.51K | -44.1% | $5.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 148.51K | -44.1% | $5.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 148.51K | -44.1% | $5.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 148.51K | -44.1% | $5.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 45 | Two Sigma Investments ✦ | 115.95K | -17.6% | $4.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 46 | T. Rowe Price ✦ | 49.28K | +7.7% | $1.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Norges Bank ✦ (passive) | 20.04K | -75.7% | $737,382 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Renaissance Technologies ✦ | 13.80K | -92.9% | $507,702 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $12.49M | was 0.0% |
| Fisher Asset Management | $1.55M | was 0.0% |
| D. E. Shaw & Co. | $223,350 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 279 holders, 76.80M shares, $3.56B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 854 sh · $120,220
Officer · 669 sh · $93,035
Officer · 1.60K sh · $222,227
Officer · 1.97K sh · $273,265
Officer · 1.36K sh · $189,130
Officer · 4.05K sh · $562,661
Officer, Director · 6.64K sh · $923,259
Officer · 14.21K sh · $1.84M
Officer · 2.00K sh · $245,162
Officer · 6.30K sh · $761,860
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology